What Are Longevity-Focused Research Peptides?
Longevity-focused research peptides are synthetic or naturally derived compounds studied in preclinical models for their roles in cellular aging pathways. Epitalon, FOXO4-DRI, and GHK-Cu represent three mechanistically distinct compound classes that have generated significant research interest: Epitalon for telomere biology, FOXO4-DRI for senescent cell elimination, and GHK-Cu for extracellular matrix remodeling. Epitalon is a synthetic tetrapeptide derived from the pineal gland protein Epithalamin; FOXO4-DRI is a D-amino acid retro-inverso peptide engineered to disrupt protein-protein interactions maintaining senescent cell survival; GHK-Cu is a naturally occurring copper-tripeptide complex isolated from human plasma.
Each compound operates through a distinct molecular target characterized in cell culture and animal model systems — which makes this comparison practically relevant for performance research labs selecting tools for aging biology studies. All three are available from Prove It Performance for research purposes only and are not intended for human or veterinary use.
How Does Epitalon Affect Telomerase Activity in Research Models?
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide with molecular formula C₁₄H₂₂N₄O₉ and molecular weight 390.4 g/mol (CAS: 76066-85-2), derived from the endogenous pineal gland peptide Epithalamin. In cell culture studies, Epitalon has been reported to increase telomerase activity and promote telomere elongation in human somatic cells through upregulation of hTERT, the catalytic subunit of the telomerase holoenzyme [PMID: 19619679]. Khavinson and colleagues published extensively on geroprotective effects in rodent aging models, including observations of extended mean lifespan and modulation of neuroendocrine function [PMID: 14696864]. Additional research examined Epitalon's influence on melatonin synthesis enzymes in pinealocyte cultures, suggesting interactions with the arylalkylamine N-acetyltransferase pathway [PMID: 26637836].
For performance research labs studying cellular senescence and aging biology, Epitalon's hTERT-directed mechanism offers a distinct tool from FOXO4-DRI's apoptosis-based approach and GHK-Cu's extracellular matrix focus. All Epitalon supplied by Prove It Performance is for research purposes only.
What Is FOXO4-DRI's Mechanism in Senescent Cell Research?
FOXO4-DRI is a D-amino acid retro-inverso peptide derived from a segment of the FOXO4 transcription factor. Its mechanism centers on disrupting the FOXO4–p53 protein-protein interaction — a signaling axis that keeps senescent cells alive by preventing apoptosis. In senescent cells, FOXO4 retains p53 in the nucleus, blocking the pro-apoptotic transcriptional programs p53 would otherwise activate. FOXO4-DRI competes with endogenous FOXO4 for p53 binding, freeing p53 to initiate apoptosis.
Baar et al. (2017) demonstrated in mouse models that FOXO4-DRI selectively induced apoptosis in p21-positive senescent cells while leaving healthy proliferating and quiescent cells intact [PMID: 28575659]. This selectivity classifies FOXO4-DRI as a senolytic peptide — a research category of growing interest in aging biology. Subsequent in vitro studies have used FOXO4-DRI to probe the FOXO4–p53 axis in stress-induced premature senescence [PMID: 30862748]. The compound's D-amino acid composition confers proteolytic resistance, making it well-suited for cell culture applications requiring stable intracellular delivery. FOXO4-DRI from Prove It Performance is for research purposes only.
How Does GHK-Cu Influence Tissue Remodeling Pathways?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper chelate with molecular formula C₁₄H₂₂CuN₆O₄ and molecular weight 404.8 g/mol (CAS: 49557-75-7), found endogenously in human plasma, saliva, and urine. In fibroblast culture models, GHK-Cu modulates expression of collagen-synthesizing genes and matrix metalloproteinases (MMPs), influencing extracellular matrix turnover [PMID: 21982351]. Research by Pickart and colleagues characterized GHK-Cu's copper-binding affinity and downstream effects on gene expression in fibroblast cultures, including upregulation of TGF-β signaling components [PMID: 25342275]. Additional biochemical studies reported copper-dependent superoxide dismutase-like antioxidant activity and effects on wound-healing gene networks in keratinocyte models [PMID: 19098933].
For performance research labs studying extracellular matrix biology and wound healing mechanisms, GHK-Cu's combined collagen regulation and MMP modulation profile makes it a functionally distinct research tool from the telomere-focused or senolytic compounds in this category. All GHK-Cu provided by Prove It Performance is for research purposes only.
Comparison Table
| Compound | Mechanism | Molecular Target | Molecular Weight | Research Application | Key Published Findings |
|---|---|---|---|---|---|
| Epitalon | Telomerase activation | hTERT (telomerase catalytic subunit) | 390.4 Da | Cellular aging, telomere studies | Khavinson et al. telomerase upregulation in human somatic cell cultures [PMID: 19619679] |
| FOXO4-DRI | Senescent cell apoptosis | FOXO4-p53 protein-protein interaction | ~2.8 kDa | Senolytic research | Baar et al. 2017 selective apoptosis in p21-positive senescent cells [PMID: 28575659] |
| GHK-Cu | Collagen synthesis, MMP regulation | TGF-β, extracellular matrix proteins | 404.8 Da | Wound healing, tissue remodeling | Pickart et al. MMP and collagen gene modulation in fibroblast cultures [PMID: 25342275] |
What Does Published Research Show About Each Compound?
Published literature on Epitalon reports hTERT-mediated telomere elongation in human somatic cell cultures and geroprotective effects in rodent aging models, with Khavinson's group contributing the most systematic published body of work [PMID: 19619679] [PMID: 14696864] [PMID: 26637836]. For FOXO4-DRI, the key publication by Baar et al. established selective elimination of p21-high senescent cells in vivo in mice, with measurable reduction in physical dysfunction markers associated with aging [PMID: 28575659]. Mechanistic follow-up studies used FOXO4-DRI to interrogate FOXO4 and p53 nuclear co-localization in senescence models [PMID: 30862748]. GHK-Cu research has focused on fibroblast and keratinocyte biology, consistently showing effects on collagen synthesis gene networks, MMP expression, and TGF-β pathway components [PMID: 25342275] [PMID: 21982351] [PMID: 19098933]. Across all three compounds, primary evidence derives from in vitro and preclinical animal studies. All compounds are provided by Prove It Performance for research purposes only.
Frequently Asked Questions
What is the molecular mechanism by which Epitalon is studied in telomere biology research?
Epitalon's studied mechanism centers on reported upregulation of hTERT — the catalytic reverse transcriptase subunit of the telomerase complex. Telomerase synthesizes TTAGGG repeats onto chromosome ends, counteracting progressive telomere shortening in somatic cells. Published cell culture studies report increased telomerase enzymatic activity measured by TRAP (Telomeric Repeat Amplification Protocol) assay and elongation of mean telomere length by Southern blot [PMID: 19619679]. Khavinson and colleagues proposed that Epitalon's structural similarity to endogenous Epithalamin permits interaction with transcriptional regulators of hTERT expression [PMID: 14696864]. This positions Epitalon as a tool for probing telomerase regulatory pathways in aging cell models. All Epitalon from Prove It Performance is for research purposes only.
How does FOXO4-DRI selectively target senescent cells in research models?
FOXO4-DRI exploits a survival dependency specific to senescent cells. In senescent cells, FOXO4 accumulates in the nucleus and sequesters p53 away from its pro-apoptotic targets, enabling cell survival despite chronic DNA damage signals. FOXO4-DRI competes with endogenous FOXO4 for binding at p53's proline-rich domain, disrupting this interaction and allowing p53 to activate apoptotic programs [PMID: 28575659]. Proliferating and quiescent cells, which do not depend on FOXO4–p53 survival signaling, show minimal response. The D-amino acid retro-inverso configuration provides proteolytic stability without altering spatial pharmacophore geometry. Researchers have used FOXO4-DRI to probe the functional contribution of specific senescent cell populations to tissue phenotypes [PMID: 30862748]. All FOXO4-DRI from Prove It Performance is for research purposes only.
What is the role of copper in GHK-Cu's activity in tissue remodeling studies?
Copper is structurally integral to GHK-Cu, not incidental. Copper coordinates to the histidine imidazole, glycine amine, and lysine side-chain amine groups of the GHK tripeptide, forming a stable square-planar complex with high binding affinity (log K ~16). This coordination enables GHK-Cu to function as a copper chaperone, facilitating copper delivery to copper-dependent enzymes including lysyl oxidase — which cross-links collagen and elastin precursors in the extracellular matrix. Published research shows that copper delivery via GHK-Cu upregulates collagen-synthesizing gene networks in fibroblast cultures more efficiently than free copper salts, suggesting the peptide carrier modifies cellular uptake and compartmentalization [PMID: 25342275]. Removal of copper from the complex abolishes the majority of bioactivity in published in vitro models [PMID: 21982351]. All GHK-Cu from Prove It Performance is for research purposes only.
How do researchers quantify telomerase activity in Epitalon studies?
The primary assay is TRAP (Telomeric Repeat Amplification Protocol): cell extracts are used to extend a telomerase substrate oligonucleotide in vitro, followed by PCR amplification and gel electrophoresis or qPCR detection of the resulting ladder-pattern products [PMID: 19619679]. Telomere length is assessed via Southern blot analysis of restriction fragment lengths (TRF assay) or qPCR-based telomere length measurement relative to a single-copy gene standard. hTERT mRNA expression by RT-PCR and hTERT protein levels by Western blot complement enzymatic activity measurements [PMID: 14696864]. Well-designed controls include telomerase-negative somatic lines and telomerase-expressing cancer lines to validate assay sensitivity. Compound purity verification by HPLC before experimental use is required.
What research models are used to study senolytic peptides like FOXO4-DRI?
In vitro: stress-induced premature senescence (SIPS) models using ionizing radiation, replicative exhaustion, or oncogene activation to generate p21-high, SA-β-galactosidase-positive senescent populations. FOXO4-DRI efficacy is assessed by measuring apoptotic markers including cleaved caspase-3, annexin V positivity, and cytochrome c release [PMID: 28575659]. Selectivity is confirmed by parallel treatment of proliferating and quiescent counterpart populations. In vivo: naturally aged mice and fast-aging progeroid strains (Ercc1-deficient models) have been used to assess senescent cell burden reduction following senolytic treatment [PMID: 28575659]. Clearance is confirmed by p21 and p16 immunostaining and SASP cytokine profiling. FOXO4-DRI from Prove It Performance is intended for these preclinical research contexts only.
All compounds listed are for research purposes only. Prove It Performance provides research-grade peptides intended for laboratory and preclinical research. Not for human or veterinary use.